Athira Pharma, Inc. (ATHA) Tops Q1 EPS by 11c
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.69), $0.11 better than the analyst estimate of ($0.80).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.69), $0.11 better than the analyst estimate of ($0.80).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.